Modelska et al. reported that eIF4A1 upregulation is associated with a higher histological grade in estrogen receptor-negative breast cancer tumors, and the combination of eIF4A1 with eIF4B and eIF4E might serve as an independent predictor of prognosis in patients with breast cancer (Modelska et al., 2015b). Here, EIF4A1 is linked to breast cancer.